Ep. 87 – Korea’s Biotech Playbook: Orum CEO SJ Lee on Going Global and Creating Novel Therapies
The BioCentury Show
00:00
Intro
This chapter explores the dynamic biotech landscape in Korea, with a focus on a company excelling in degrader antibody conjugates and its successful cross-border operations. It highlights Western biopharmaceutical interest in Korean innovation, recent investments, and sets the stage for the upcoming BioCentury East-West Conference.
Play episode from 00:00
Transcript
